proprietary computer-generated scheme (Accovion Inc)
90
Structured Review
Accovion Inc
proprietary computer-generated scheme
Proprietary Computer Generated Scheme, supplied by Accovion Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+scheme/proprietary+computer+generated+scheme/pm26725544-46-11-13
Average 90 stars, based on 1 article reviews
Proprietary Computer Generated Scheme, supplied by Accovion Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+scheme/proprietary+computer+generated+scheme/pm26725544-46-11-13
Average 90 stars, based on 1 article reviews
proprietary computer-generated scheme - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial. Article Snippet: Methods We did a randomised, double-blind, placebo-controlled and active-controlled trial of opicapone as an adjunct to levodopa in patients with Parkinson’s disease with end-of-dose motor fl uctuations.. Patients aged 30–83 years were enrolled at 106 specialist centres across 19 European countries and Russia and were randomly assigned (1:1:1:1:1) by a proprietary computer-generated sequence to oral treatment with opicapone (5 mg, 25 mg, or 50 mg once daily), placebo, or entacapone (200 mg with every levodopa intake) for 14–15 weeks.. Patients and investigators (ie, outcome assessors) were masked to treatment allocation. |